Genentech has opened its $400 million manufacturing center in Hillsboro, providing a big boost to Oregon's aspirations for bioscience.
The San Francisco-based company has 250 employees working at the new center.
The drugmaker, acquired last year by Swiss-based Roche Holdings for $46.8 billion, comes with a global reach and loads of growth potential.
Genentech brings valuable experience, knowledge and industry cachet to Oregon, according to Arundeep Pradhan, vice president of technology transfer and business development at Oregon Health & Science University.
Read the full story at OregonLive.com.